According to the Korea Disease Management Agency (CDC), on November 17, Korea recorded 313 new Covid-19 cases, bringing the total number of cases in the country to 29,311 people.
This is the first time in 81 days, the number of new cases has risen to 300, since August 29 (323 people), a time of large-scale outbreak of collective infection in Seoul and the provinces surrounding the capital.
Among the new cases, there are 245 cases arising in the community, 68 cases are imported. The number of Covid-19 cases of people entering the day was also at the highest level since late July.
The epidemic prevention agency was concerned that, unlike previous cases of large-scale collective infection, which mainly occurred in a certain group of people, recent cases of collective infection occurred simultaneously in many places, related to people’s daily lives, such as food gatherings, when people had to remove their masks. Therefore, the epidemic prevention agency once again suggested that people strictly abide by the anti-epidemic rules, because anyone can be infected with Covid-19 anywhere, anytime. In addition, people should limit eating, gathering, and minimizing unnecessary movement and contact with others.
Meanwhile, at the plenary meeting of the Health and Welfare Committee of the National Assembly, the Korean Minister of Health and Welfare said the quantity and price were negotiating with foreign businesses to develop vaccines. Covid-19.
Currently, if including companies that have launched Covid-19 vaccine sales to Korea, the number of vaccines has reached over 30 million doses. The Minister of Health confirmed that they were negotiating actively, and did not appear too urgent to receive reasonable prices from suppliers.
Fortunately, the vaccine of the pharmaceutical company AstraZeneca (based in the UK) will be produced in Korea, so this is a favorable condition for Korea to ensure the vaccine quantity.
Previously, the Vice Chairman of the Central Committee for Prevention of Epidemic Disposition of Korea at a regular press conference also said that Korea was negotiating to buy five Covid-19 vaccines from abroad, which is currently in the process of clinical trials stage 3. /.